Foot-and-Mouth Disease
By M. Grubman, B. Baxt. Clinical Microbiology Reviews, 2004
1,186 citations recorded by the source corpus.
SUMMARY Foot-and-mouth disease (FMD) is a highly contagious disease of cloven-hoofed animals. The disease was initially described in the 16th century and was the first animal pathogen identified as a virus. Recent FMD outbreaks in developed countries and their significant economic impact have increased the concern of governments worldwide. This review describes the reemergence of FMD in developed countries that had been disease free for many years and the effect that this has had on disease control strategies. The etiologic agent, FMD virus (FMDV), a member of the Picornaviridae family, is examined in detail at the genetic, structural, and biochemical levels and in terms of its antigenic diversity. The virus replication cycle, including virus-receptor interactions as well as unique aspects of virus translation and shutoff of host macromolecular synthesis, is discussed. This information has been the basis for the development of improved protocols to rapidly identify disease outbreaks, to differentiate vaccinated from infected animals, and to begin to identify and test novel vaccine candidates. Furthermore, this knowledge, coupled with the ability to manipulate FMDV genomes at the molecular level, has provided the framework for examination of disease pathogenesis and the development of a more complete understanding of the virus and host factors involved.
Subfields: Agronomy and Crop Science, Cardiology and Cardiovascular Medicine, Ecology, Evolution, Behavior and Systematics
View Paper: https://www.semanticscholar.org/paper/8b90fcdac670b4deb7b25af75c0af64c95b4d73a
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Ecology, Evolution, Behavior and Systematics
Citations in the corpus
- Contacts and foot and mouth disease transmission from wild to domestic bovines in Africa (2013, background): “As for the vaccinal antibodies, they may persist on average for one year but re-booster vaccination sessions every 6 months are recommended in endemic areas to effectively protect host individuals (Thomson et al. 2003, Grubman and Baxt 2004, Cloete et al. 2008, Paton et al. 2009, Charleston 2011).”